论文部分内容阅读
目的:探讨HCV复制水平与肝病进展的关系。方法:用竞争性逆转录聚合酶链反应(CRT-PCR)定量检测27例慢性丙肝患者(CHC)血清HCVRNA。结果:CHC患者血清HCVRNA水平变化范围102~106copies/50ulserum。13例慢性迁延性肝炎(CPH)患者血清HCVRNA平均水平(5.068±1.04,Log10copies/50μlserum)明显低于10例慢性活动性肝炎患者(CAH)(5.79±0.25)和4例肝硬化(Cir)患者(5.83±0.75),P值均<0.05。血清HCVRNA水平同ALT水平间呈正相关(r=0.4997,P值<0.05)。结论:表明丙肝病毒感染后病毒血症水平低,HCV复制水平与肝损伤相关,在慢性感染中HCV仍活跃复制,并与肝病进展相关。
Objective: To investigate the relationship between the level of HCV replication and the progress of liver disease. Methods: Serum HCV RNA of 27 chronic hepatitis C patients (CHC) was quantitatively detected by competitive reverse transcription polymerase chain reaction (CRT-PCR). Results: Serum HCV RNA levels varied from 102 to 106 cops / 50 ulserum in CHC patients. The average level of serum HCVRNA in 13 patients with chronic persistent hepatitis (CPH) (5.068 ± 1.04, Log10copies / 50μlserum) was significantly lower than that in 10 patients with chronic active hepatitis (CAH) (5.79 ± 0.25) and Four patients with cirrhosis (Cir) were (5.83 ± 0.75), P <0.05. Serum HCV RNA levels were positively correlated with ALT levels (r = 0.4997, P <0.05). CONCLUSIONS: This indicates that the level of viremia after HCV infection is low, the level of HCV replication is associated with liver injury, and HCV is still actively replicated in chronic infections and is associated with progression of liver disease.